Literature DB >> 12145534

Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism.

Vijendra K Singh1, Sheren X Lin, Elizabeth Newell, Courtney Nelson.   

Abstract

Autoimmunity to the central nervous system (CNS), especially to myelin basic protein (MBP), may play a causal role in autism, a neurodevelopmental disorder. Because many autistic children harbor elevated levels of measles antibodies, we conducted a serological study of measles-mumps-rubella (MMR) and MBP autoantibodies. Using serum samples of 125 autistic children and 92 control children, antibodies were assayed by ELISA or immunoblotting methods. ELISA analysis showed a significant increase in the level of MMR antibodies in autistic children. Immunoblotting analysis revealed the presence of an unusual MMR antibody in 75 of 125 (60%) autistic sera but not in control sera. This antibody specifically detected a protein of 73-75 kD of MMR. This protein band, as analyzed with monoclonal antibodies, was immunopositive for measles hemagglutinin (HA) protein but not for measles nucleoprotein and rubella or mumps viral proteins. Thus the MMR antibody in autistic sera detected measles HA protein, which is unique to the measles subunit of the vaccine. Furthermore, over 90% of MMR antibody-positive autistic sera were also positive for MBP autoantibodies, suggesting a strong association between MMR and CNS autoimmunity in autism. Stemming from this evidence, we suggest that an inappropriate antibody response to MMR, specifically the measles component thereof, might be related to pathogenesis of autism. Copyright 2002 National Science Council, ROC and S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145534     DOI: 10.1007/bf02256592

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  16 in total

1.  A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety.

Authors:  Peter I Folb; Ewa Bernatowska; Robert Chen; John Clemens; Alex N O Dodoo; Susan S Ellenberg; C Patrick Farrington; T Jacob John; Paul-Henri Lambert; Noni E Macdonald; Elizabeth Miller; David Salisbury; Heinz-J Schmitt; Claire-Anne Siegrist; Omala Wimalaratne
Journal:  Am J Public Health       Date:  2004-11       Impact factor: 9.308

2.  Strategies for selective priming of memory B cells.

Authors:  Vanitha S Raman; Evan F Lind; Micah J Benson; Randolph J Noelle
Journal:  Immunol Lett       Date:  2007-02-27       Impact factor: 3.685

Review 3.  Autistic disorder and viral infections.

Authors:  Jane E Libbey; Thayne L Sweeten; William M McMahon; Robert S Fujinami
Journal:  J Neurovirol       Date:  2005-02       Impact factor: 2.643

4.  Prevalence of HSV1/2 Congenital Infection Assessed Through Genome Detection on Dried Blood Spot in Individuals with Autism Spectrum Disorders.

Authors:  Emanuela Zappulo; Maria Pia Riccio; Sandro Binda; Laura Pellegrinelli; Fabrizio Pregliasco; Antonio Riccardo Buonomo; Biagio Pinchera; Giordano D'Urso; Carmela Bravaccio; Guglielmo Borgia; Ivan Gentile
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

5.  Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.

Authors:  Boris Sakic; David L Kirkham; David A Ballok; James Mwanjewe; Ian M Fearon; Joseph Macri; Guanhua Yu; Michelle M Sidor; Judah A Denburg; Henry Szechtman; Jonathan Lau; Alexander K Ball; Laurie C Doering
Journal:  J Neuroimmunol       Date:  2005-09-29       Impact factor: 3.478

6.  Prevalence of Congenital Cytomegalovirus Infection Assessed Through Viral Genome Detection in Dried Blood Spots in Children with Autism Spectrum Disorders.

Authors:  Ivan Gentile; Emanuela Zappulo; Maria Pia Riccio; Sandro Binda; Laura Bubba; Laura Pellegrinelli; Domenico Scognamiglio; Francesca Operto; Lucia Margari; Guglielmo Borgia; Carmela Bravaccio
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

7.  Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes.

Authors:  Paul Ashwood; Amanda Enstrom; Paula Krakowiak; Irva Hertz-Picciotto; Robin L Hansen; Lisa A Croen; Sally Ozonoff; Isaac N Pessah; Judy Van de Water
Journal:  J Neuroimmunol       Date:  2008-11-15       Impact factor: 3.478

8.  Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study.

Authors:  Lisa A Croen; Daniel Braunschweig; Lori Haapanen; Cathleen K Yoshida; Bruce Fireman; Judith K Grether; Martin Kharrazi; Robin L Hansen; Paul Ashwood; Judy Van de Water
Journal:  Biol Psychiatry       Date:  2008-06-20       Impact factor: 13.382

Review 9.  Autoimmunity in autism.

Authors:  Amanda M Enstrom; Judy A Van de Water; Paul Ashwood
Journal:  Curr Opin Investig Drugs       Date:  2009-05

10.  Are there altered antibody responses to measles, mumps, or rubella viruses in autism?

Authors:  Jane E Libbey; Hilary H Coon; Nikki J Kirkman; Thayne L Sweeten; Judith N Miller; Janet E Lainhart; William M McMahon; Robert S Fujinami
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.